Journal article
Predictors of response to secukinumab in patients with psoriatic arthritis and axial manifestations: a post-hoc analysis of the MAXIMISE trial
- Abstract:
-
Objectives To investigate patient characteristics predictive of response to secukinumab in patients with psoriatic arthritis (PsA) with axial manifestations.
Methods In a post-hoc analysis from the MAXIMISE trial (NCT02721966) in patients with PsA and axial manifestations, we tested the hypothesis that the OR of the effect of treatment on the primary endpoint of the trial (Assessment of SpondyloArthritis international Society (ASAS) 20 responder status a... Expand abstract
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 1.4MB, Terms of use)
-
- Publisher copy:
- 10.1136/rmdopen-2022-002303
Authors
Bibliographic Details
- Publisher:
- BMJ Publishing Group
- Journal:
- RMD Open More from this journal
- Volume:
- 8
- Issue:
- 2
- Article number:
- e002303
- Publication date:
- 2022-07-18
- Acceptance date:
- 2022-07-02
- DOI:
- EISSN:
-
2056-5933
Item Description
- Language:
-
English
- Keywords:
- Pubs id:
-
1266537
- Local pid:
-
pubs:1266537
- Deposit date:
-
2022-07-04
Terms of use
- Copyright holder:
- Baraliakos et al.
- Copyright date:
- 2022
- Rights statement:
- ©2022 Author(s) (or their employer(s)). Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial.
Metrics
If you are the owner of this record, you can report an update to it here: Report update to this record